ACH · XBRL financial data

Accendra Health financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ACH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	2,592	2,656*	2,613	2,671	2,721	2,696*	2,632	682	697	709*	628	613
Cost of revenue	2,053	2,086*	2,077	2,127	2,161	2,116*	2,106	357	375	386*	350	350
Gross profit	538	570*	536	544	560	580*	526	—	—	323*	—	—
Research and development	—	year only	—	—	—	year only	—	—	—	—	—	—
Selling, general and administrative	453	457*	478	469	470	493*	462	268	266	271*	255	244
Other operating income (expense)	(2)	(2)*	(1)	(5)	(16)	8*	(3)	—	—	—	—	—
Operating income (loss)	24	60*	10	20	24	(262)*	0	(40)	26	21*	17	(35)
Interest expense	38	37*	36	36	37	36*	34	26	29	28*	32	35
Income tax expense (benefit)	(5)	3*	(5)	15	(1)	(4)*	(10)	(1)	2	1*	(10)	1
Net income (loss)	(6)	18*	(22)	(32)	(13)	(296)*	(25)	(869)	(150)	(56)*	(6)	(89)
Earnings per share, basic USD per share	(0.08)	0.23*	(0.29)	(0.42)	(0.17)	(3.85)*	(0.32)	(11.30)	(1.94)	(0.74)*	(0.08)	(1.16)
Earnings per share, diluted USD per share	(0.08)	0.23*	(0.29)	(0.42)	(0.17)	(3.85)*	(0.32)	(11.30)	(1.94)	(0.74)*	(0.08)	(1.16)
Weighted average shares, basic millions of shares	76	76*	76	77	77	77*	77	77	77	76*	76	77
Weighted average shares, diluted millions of shares	76	76*	76	77	77	77*	77	77	77	76*	76	77

Fiscal quarters (ACH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	215	243	245	244	45	49	59	38	33	282	337	8
Inventory	1,084	1,111	1,145	1,231	1,242	1,132	1,409	69	64	74	65	73
Total current assets	2,130	2,103	2,236	2,327	2,117	2,021	2,206	2,299	2,132	548	589	271
Property and equipment, net	—	—	—	—	—	249	—	259	260	256	228	209
Right-of-use asset	300	297	350	368	357	356	383	120	119	109	102	97
Goodwill	1,635	1,639	1,635	1,635	1,642	1,331	1,332	1,228	1,228	1,228	1,228	1,228
Total assets	5,124	5,093	5,208	5,304	5,081	4,656	4,856	4,155	4,036	2,452	2,416	2,107
Accounts payable	1,182	1,172	1,219	1,382	1,338	1,252	1,381	357	340	364	375	353
Current portion of long-term debt	—	207	208	211	43	46	50	383	280	250	581	0
Total current liabilities	1,732	1,892	1,933	2,131	1,934	1,874	1,960	2,675	2,466	947	1,203	666
Lease liability, non-current	225	222	276	298	288	286	324	81	81	70	67	63
Total liabilities	4,237	4,169	4,313	4,443	4,207	4,091	4,285	4,436	4,466	2,913	2,881	2,658
Retained earnings (accumulated deficit)	351	369	347	315	302	6	1	(872)	(1,022)	(1,080)	(1,086)	(1,175)
Total stockholders' equity	887	924	895	861	875	565	571	(281)	(430)	(461)	(465)	(551)
Total liabilities and equity	5,124	5,093	5,208	5,304	5,081	4,656	4,856	4,155	4,036	2,452	2,416	2,107
Common shares outstanding (cover page) millions of shares	77	77	76	77	77	77	77	77	77	76	77	77

Fiscal quarters (ACH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(6)	18*	(22)	(32)	(13)	(296)*	(25)	(869)	(150)	(56)*	(6)	(89)
Stock-based compensation	6*	6*	7	7*	6*	8*	7	8*	2*	(4)*	3	4*
Depreciation and amortization	74	71*	74	64	62	65*	61	59*	64*	30*	62	66*
Net cash from operating activities	157*	112*	(53)	116*	27*	71*	(35)	38*	(173)*	—	—	—
Purchases of property and equipment	48*	50*	46	44*	58*	63*	46	78*	54*	13*	42	48*
Net cash from investing activities	(33)*	(39)*	(2)	(35)*	(27)*	(52)*	(48)	(53)*	(39)*	285*	54	(31)*
Share repurchases	—	—	0	0*	0*	—	2	5*	0*	4*	0	—
Dividends paid	—	year only	—	—	—	—	—	—	—	—	—	—
Repayments of long-term debt	192*	51*	5	8*	199*	33*	0	0*	0*	—	—	—
Net cash from financing activities	(183)*	(51)*	53	(78)*	(200)*	(43)*	93	32*	181*	(117)*	51	(272)*
Net change in cash	(59)*	23*	(2)	3*	(198)*	(26)*	10	18*	(31)*	236*	55	(329)*

SIC 5047 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 5047 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Accendra Health	7.7	613	not reported	76.9M	—	Q2 FY26 10-QJun 30, 2026
PC Connection	125	874	9.7*	25.2M	—	Q3 FY26 10-QSep 30, 2026
Scansource	88	953*	(2.3)*	20.1M	38.9 quarters	Q4 FY26 10-KJun 30, 2026
Ingram Micro Holding	1,004	15,220	251*	230.1M	—	Q3 FY26 10-QSep 26, 2026
Climb Global Solutions	67	220	12*	18.7M	—	Q3 FY26 10-QSep 30, 2026
Eplus	449	649	76	26.1M	—	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.